Science Explorer Back to mapMap
Discussion
Company · Basel · Switzerland

Novartis (Switzerland)

In research, Novartis (Switzerland) stands highest in Health Sciences (#369 of 9,902 worldwide), Medicine (#352 of 8,541 worldwide) and Life Sciences (#332 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Hematology, Genetics and Statistics and Probability (Hematology is 15.1× its share of world research).

novartis.comROR OpenAlex
World rank, 2022-now
#697
of 22,385 · #636 all time
Rank in Switzerland
#13
of 186
Research works
25k
▼ 19% vs 2018-21
Citations
1M
42.6 per fractional work
Top-10% rate
14.3%
all institutions 10.0%
vs its own fields
1.30×
1.00× is exactly expected
Open access
31%
world 40%
International
40%
world 18%
Novartis (Switzerland)

What is Novartis (Switzerland) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #369 of 9,902 15.2%1,069 #282
MedicineField #352 of 8,541 15.4%1,028 #267
Life SciencesDomain #332 of 6,403 15.9%474 #301
Biochemistry, Genetics and Molecular BiologyField #253 of 2,964 18.3%273 #254
Molecular BiologySubfield #209 of 1,880 19.8%193 #206
Physical SciencesDomain #1,336 of 10,670 12.4%264 #1244
ChemistryField #374 of 1,299 14.2%70 #315
ImmunologySubfield #140 of 480 12.5%102 #166
Immunology and MicrobiologyField #207 of 681 12.7%107 #172
SurgerySubfield #467 of 1,532 17.3%66 #521

Each strip is that field's whole ranked pool, with the notch where Novartis (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#282 #369
  2. Medicine#267 #352
  3. Life Sciences#301 #332
  4. Biochemistry, Genetics and Molecular Biology#254 #253
  5. Molecular Biology#206 #209
  6. Physical Sciences#1,244 #1,336
  7. Chemistry#315 #374
  8. Immunology#166 #140
  9. Immunology and Microbiology#172 #207
  10. Surgery#521 #467
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Novartis (Switzerland) work in?

In 2022-now, 54% of research at Novartis (Switzerland) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (5%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 1,164 fractional works · 54.5% of its workMedicine: 1,119 fractional works · 52.4% of its workOncology: 103 fractional works · 4.8% of its workHematology: 98 fractional works · 4.6% of its workPulmonary and Respiratory Medicine: 90 fractional works · 4.2% of its workGenetics: 83 fractional works · 3.9% of its workRheumatology: 76 fractional works · 3.5% of its workSurgery: 72 fractional works · 3.4% of its workPathology and Forensic Medicine: 58 fractional works · 2.7% of its workCardiology and Cardiovascular Medicine: 53 fractional works · 2.5% of its workRadiology, Nuclear Medicine and Imaging: 52 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 51 fractional works · 2.4% of its workEpidemiology: 44 fractional works · 2.1% of its workPhysiology: 44 fractional works · 2.1% of its workNephrology: 33 fractional works · 1.6% of its workOphthalmology: 33 fractional works · 1.6% of its workDermatology: 28 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 24 fractional works · 1.1% of its workNeurology: 23 fractional works · 1.1% of its workEndocrinology, Diabetes and Metabolism: 21 fractional works · 1.0% of its workPsychiatry and Mental health: 21 fractional works · 1.0% of its workPharmacology: 21 fractional works · 1.0% of its workInfectious Diseases: 18 fractional works · 0.8% of its workImmunology and Allergy: 13 fractional works · 0.6% of its workHepatology: 12 fractional works · 0.6% of its workFamily Practice: 9 fractional works · 0.4% of its workSmaller subfields together: 39 fractional works · 1.8% of its workHealth Professions: 35 fractional works · 1.6% of its workGeneral Health Professions: 19 fractional works · 0.9% of its workSmaller subfields together: 16 fractional works · 0.7% of its workVeterinary: 5 fractional works · 0.3% of its workSmall Animals: 5 fractional works · 0.3% of its workNursing: 2 fractional works · 0.1% of its workDentistry: 2 fractional works · 0.1% of its workLife Sciences: 522 fractional works · 24.5% of its workBiochemistry, Genetics and Molecular Biology: 303 fractional works · 14.2% of its workMolecular Biology: 213 fractional works · 10.0% of its workCancer Research: 28 fractional works · 1.3% of its workGenetics: 24 fractional works · 1.1% of its workCell Biology: 18 fractional works · 0.8% of its workBiotechnology: 5 fractional works · 0.2% of its workBiophysics: 5 fractional works · 0.2% of its workSmaller subfields together: 11 fractional works · 0.5% of its workImmunology and Microbiology: 117 fractional works · 5.5% of its workImmunology: 111 fractional works · 5.2% of its workSmaller subfields together: 6 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 42 fractional works · 2.0% of its workPharmacology: 20 fractional works · 0.9% of its workPharmaceutical Science: 18 fractional works · 0.9% of its workSmaller subfields together: 4 fractional works · 0.2% of its workNeuroscience: 30 fractional works · 1.4% of its workCellular and Molecular Neuroscience: 10 fractional works · 0.5% of its workNeurology: 9 fractional works · 0.4% of its workCognitive Neuroscience: 5 fractional works · 0.2% of its workSmaller subfields together: 6 fractional works · 0.3% of its workAgricultural and Biological Sciences: 29 fractional works · 1.4% of its workEcology, Evolution, Behavior and Systematics: 10 fractional works · 0.5% of its workPlant Science: 8 fractional works · 0.4% of its workFood Science: 6 fractional works · 0.3% of its workSmaller subfields together: 5 fractional works · 0.3% of its workPhysical Sciences: 294 fractional works · 13.8% of its workChemistry: 75 fractional works · 3.5% of its workOrganic Chemistry: 50 fractional works · 2.3% of its workSpectroscopy: 12 fractional works · 0.6% of its workAnalytical Chemistry: 7 fractional works · 0.3% of its workSmaller subfields together: 7 fractional works · 0.3% of its workEngineering: 62 fractional works · 2.9% of its workBiomedical Engineering: 34 fractional works · 1.6% of its workControl and Systems Engineering: 7 fractional works · 0.3% of its workElectrical and Electronic Engineering: 6 fractional works · 0.3% of its workSmaller subfields together: 14 fractional works · 0.7% of its workComputer Science: 57 fractional works · 2.7% of its workComputational Theory and Mathematics: 28 fractional works · 1.3% of its workArtificial Intelligence: 15 fractional works · 0.7% of its workInformation Systems: 6 fractional works · 0.3% of its workSmaller subfields together: 8 fractional works · 0.4% of its workMathematics: 51 fractional works · 2.4% of its workStatistics and Probability: 50 fractional works · 2.3% of its workSmaller subfields together: 1 fractional works · 0.1% of its workMaterials Science: 20 fractional works · 0.9% of its workMaterials Chemistry: 16 fractional works · 0.7% of its workSmaller subfields together: 5 fractional works · 0.2% of its workEnvironmental Science: 18 fractional works · 0.9% of its workEnvironmental Chemistry: 6 fractional works · 0.3% of its workHealth, Toxicology and Mutagenesis: 6 fractional works · 0.3% of its workSmaller subfields together: 7 fractional works · 0.3% of its workPhysics and Astronomy: 7 fractional works · 0.3% of its workChemical Engineering: 2 fractional works · 0.1% of its workEarth and Planetary Sciences: 1 fractional works · 0.1% of its workEnergy: 1 fractional works · 0.0% of its workSocial Sciences: 155 fractional works · 7.3% of its workEconomics, Econometrics and Finance: 87 fractional works · 4.1% of its workEconomics and Econometrics: 83 fractional works · 3.9% of its workSmaller subfields together: 4 fractional works · 0.2% of its workSocial Sciences: 21 fractional works · 1.0% of its workSociology and Political Science: 8 fractional works · 0.4% of its workHealth: 5 fractional works · 0.2% of its workSmaller subfields together: 8 fractional works · 0.4% of its workPsychology: 16 fractional works · 0.7% of its workClinical Psychology: 5 fractional works · 0.2% of its workSmaller subfields together: 11 fractional works · 0.5% of its workDecision Sciences: 15 fractional works · 0.7% of its workStatistics, Probability and Uncertainty: 8 fractional works · 0.4% of its workManagement Science and Operations Research: 6 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.1% of its workBusiness, Management and Accounting: 11 fractional works · 0.5% of its workArts and Humanities: 5 fractional works · 0.2% of its workALL ITS WORKNovartis(Switzerland)2,136fractional works, 2022-now
Life Sciences24%Physical Sciences14%Health Sciences54%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
  1. Health Sciences1,16454.5%
    1. Medicine1,11952.4%
    2. Health Professions351.6%
    3. Veterinary50.3%
    4. Nursing20.1%
    5. Dentistry20.1%
    1. Biochemistry, Genetics and Molecular Biology30314.2%
    2. Immunology and Microbiology1175.5%
    3. Pharmacology, Toxicology and Pharmaceutics422.0%
    4. Neuroscience301.4%
    5. Agricultural and Biological Sciences291.4%
    1. Chemistry753.5%
    2. Engineering622.9%
    3. Computer Science572.7%
    4. Mathematics512.4%
    5. Materials Science200.9%
    6. Environmental Science180.9%
    7. Physics and Astronomy70.3%
    8. Chemical Engineering20.1%
    9. Earth and Planetary Sciences10.1%
    10. Energy10.0%
    1. Economics, Econometrics and Finance874.1%
    2. Social Sciences211.0%
    3. Psychology160.7%
    4. Decision Sciences150.7%
    5. Business, Management and Accounting110.5%
    6. Arts and Humanities50.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Novartis (Switzerland) specialise in?

Where its research is concentrated relative to its size: Hematology takes 15.1× the share of its output that it takes of world research.

  1. HematologySubfield · 97.5 works15×
  2. GeneticsSubfield · 83.2 works14×
  3. Statistics and ProbabilitySubfield · 49.5 works11×
  4. RheumatologySubfield · 75.7 works7.8×
  5. ImmunologySubfield · 110.7 works7.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 29 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.66× its world share, 304 worksBiochemistry, Geneti…Immunology and Microbiology: 5.44× its world share, 117 worksImmunology and Micro…Neuroscience: 0.87× its world share, 30 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.61× its world share, 42 worksPharmacology, Toxico…Chemical Engineering: 0.22× its world share, 2 worksChemical EngineeringChemistry: 2.24× its world share, 75 worksChemistryComputer Science: 0.34× its world share, 57 worksComputer ScienceEarth and Planetary Sciences: 0.03× its world share, 1 worksEarth and Planetary …Energy: 0.05× its world share, 1 worksEnergyEngineering: 0.19× its world share, 62 worksEngineeringEnvironmental Science: 0.17× its world share, 18 worksEnvironmental ScienceMaterials Science: 0.27× its world share, 20 worksMaterials ScienceMathematics: 2.02× its world share, 51 worksMathematicsPhysics and Astronomy: 0.15× its world share, 7 worksPhysics and AstronomyDentistry: 0.22× its world share, 2 worksDentistryHealth Professions: 0.61× its world share, 35 worksHealth ProfessionsMedicine: 2.73× its world share, 1,119 worksMedicineNursing: 0.23× its world share, 2 worksNursingVeterinary: 1.89× its world share, 6 worksVeterinaryArts and Humanities: 0.08× its world share, 5 worksArts and HumanitiesBusiness, Management and Accounting: 0.16× its world share, 11 worksBusiness, Management…Decision Sciences: 0.75× its world share, 16 worksDecision SciencesEconomics, Econometrics and Finance: 1.90× its world share, 87 worksEconomics, Econometr…Psychology: 0.24× its world share, 16 worksPsychologySocial Sciences: 0.08× its world share, 21 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.6×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.61×42 works
  2. Immunology and Microbiology5.44×117 works
  3. Medicine2.73×1,119 works
  4. Biochemistry, Genetics and Molecular Biology2.66×304 works
  5. Chemistry2.24×75 works
  6. Mathematics2.02×51 works
  7. Economics, Econometrics and Finance1.90×87 works
  8. Veterinary1.89×6 works
  9. Neuroscience0.87×30 works
  10. Decision Sciences0.75×16 works
  11. Health Professions0.61×35 works
  12. Computer Science0.34×57 works
  13. Agricultural and Biological Sciences0.29×29 works
  14. Materials Science0.27×20 works
  15. Psychology0.24×16 works
  16. Nursing0.23×2 works
  17. Chemical Engineering0.22×2 works
  18. Dentistry0.22×2 works
  19. Engineering0.19×62 works
  20. Environmental Science0.17×18 works
  21. Business, Management and Accounting0.16×11 works
  22. Physics and Astronomy0.15×7 works
  23. Arts and Humanities0.08×5 works
  24. Social Sciences0.08×21 works
  25. Energy0.05×1 works
  26. Earth and Planetary Sciences0.03×1 works

Who are the top researchers at Novartis (Switzerland)?

Ranked on the quality score, Francesco Hofmann, Markus Schirle and Tewis Bouwmeester lead among researchers whose main affiliation is Novartis (Switzerland).

  1. 1 Francesco Hofmann Switzerland · #17,370 worldwide 15k citations · 310 works
  2. 2 Markus Schirle Switzerland · #24,677 worldwide 20k citations · 143 works
  3. 3 Tewis Bouwmeester Switzerland · #34,452 worldwide 23k citations · 124 works
  4. 4 Sauveur-Michel Maira Switzerland · #36,276 worldwide 9.9k citations · 264 works
  5. 5 David A. Ruddy Switzerland · #36,886 worldwide 13k citations · 369 works
  6. 6 Andrea Kay Switzerland · #37,067 worldwide 14k citations · 86 works
  7. 7 Matthias Staufenbiel Switzerland · #44,661 worldwide 35k citations · 296 works
  8. 8 Giordano Caponigro Switzerland · #46,130 worldwide 19k citations · 303 works
  9. 9 Vic E. Myer Switzerland · #53,037 worldwide 21k citations · 67 works
  10. 10 David Lebwohl Switzerland · #57,634 worldwide 28k citations · 90 works
All ranked researchers at Novartis (Switzerland)

What are the most cited papers from Novartis (Switzerland)?

The most cited paper from Novartis (Switzerland) is "Development and testing of a general amber force field" (Junmei Wang, Romain M. Wolf, James W. Caldwell et al., 2004), with 20,214 citations. Next come "Metascape provides a biologist-oriented resource for the analysis of systems-level datasets" (16,072) and "Simultaneous Inference in General Parametric Models" (14,308).

Most cited papers
#PaperReleasedCitations
1 Development and testing of a general amber force field Junmei Wang, Romain M. Wolf, James W. Caldwell et al. · Journal of Computational Chemistry 13 Apr 2004 20,214
2 Metascape provides a biologist-oriented resource for the analysis of systems-level datasets Yingyao Zhou, Bin Zhou, Lars Pache et al. · Nature Communications Open access 3 Apr 2019 16,072
3 Simultaneous Inference in General Parametric Models Torsten Hothorn, Frank Bretz, Peter H. Westfall · Biometrical Journal Open access 15 May 2008 14,308
4 A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules Wendy D. Cornell, Piotr Cieplak, Christopher I. Bayly et al. · Journal of the American Chemical Society May 1995 13,239
5 Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Paul M. Ridker et al. · New England Journal of Medicine Open access 27 Aug 2017 9,517
All 60 most cited papers, with filters and sorting

Which keywords describe research at Novartis (Switzerland)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Clinical Trials, Inflammation, Epidemiology, Quality of Life, Autoantibodies, Diagnosis, Prognostic Factors and Economic Evaluation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology155▲ 1.82×101 topics
  2. Inflammation140▲ 3.1×76 topics
  3. Quality of Life104▲ 3.4×37 topics
  4. Clinical Trials99▲ 6.9×16 topics
  5. Diagnosis76▲ 3.8×28 topics
  6. Treatment75▲ 2.9×36 topics
  7. Cancer64▲ 2.2×45 topics
  8. Autoantibodies62▲ 12×8 topics
  9. Biomarkers58▲ 3.9×16 topics
  10. Prognostic Factors58▲ 6.2×13 topics
  11. Immunotherapy54▲ 3.5×18 topics
  12. Genetics51▲ 3.4×20 topics
  13. Economic Evaluation49▲ 20×2 topics
  14. Cost-effectiveness Analysis49▲ 29×1 topic
  15. Health Utility Measures49▲ 29×1 topic
  16. Monoclonal Antibodies48▲ 25×3 topics
  17. Mutation48▲ 12×5 topics
  18. Cancer Therapy46▲ 3.8×18 topics
  19. Medicinal Chemistry46▲ 7.9×12 topics
  20. Genetic Variants44▲ 12×7 topics
  21. Cardiovascular Disease Prevention43▲ 23×3 topics
  22. Pharmacokinetics42▲ 7.3×8 topics
  23. Diagnostic Criteria41▲ 8.3×9 topics
  24. Breast Cancer39▲ 7.3×11 topics
  25. Innate Immunity39▲ 5.7×11 topics
  26. Cytokines38▲ 6.1×8 topics
  27. Targeted Therapy38▲ 7.9×5 topics
  28. Statins36▲ 24×2 topics
  29. Rituximab36▲ 12×4 topics
  30. Resistance36▲ 16×2 topics
  31. C-Reactive Protein35▲ 22×2 topics
  32. BCR-ABL35▲ 63×1 topic
  33. Imatinib35▲ 63×1 topic
  34. Immunosuppressive Therapy34▲ 8.4×8 topics
  35. Hypercholesterolemia34▲ 38×2 topics
  36. Cholesterol-lowering34▲ 35×1 topic
  37. LDL Cholesterol34▲ 47×1 topic
  38. Therapeutic Antibodies34▲ 23×2 topics
  39. Lymphoma32▲ 9.5×4 topics
  40. Glycosylation32▲ 14×3 topics

Which research topics does Novartis (Switzerland) publish most on?

By volume in 2022-now: Health Systems, Economic Evaluations, Quality of Life, Chronic Myeloid Leukemia Treatments, Lipoproteins and Cardiovascular Health and Multiple Sclerosis Research Studies.

Health Systems, Economic…49Health Systems, Economic Evaluations, Quality of Life: 49 fractional worksChronic Myeloid Leukemia…35Chronic Myeloid Leukemia Treatments: 35 fractional worksLipoproteins and Cardiov…34Lipoproteins and Cardiovascular Health: 34 fractional worksMultiple Sclerosis Resea…29Multiple Sclerosis Research Studies: 29 fractional worksComputational Drug Discovery Methods: 27 fractional worksRenal Diseases and Glomerulopathies: 26 fractional worksStatistical Methods in C…24Statistical Methods in Clinical Trials: 24 fractional worksUrticaria and Related Conditions: 22 fractional worksComplement system in diseases: 22 fractional worksCAR-T cell therapy resea…21CAR-T cell therapy research: 21 fractional works
Economics and EconometricsHematologySurgeryPathology and Forensic Medicine6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 49 works
  2. 2 Chronic Myeloid Leukemia Treatments Hematology 35 works
  3. 3 Lipoproteins and Cardiovascular Health Surgery 34 works
  4. 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 29 works
  5. 5 Computational Drug Discovery Methods Computational Theory and Mathematics 27 works
  6. 6 Renal Diseases and Glomerulopathies Nephrology 26 works
  7. 7 Statistical Methods in Clinical Trials Statistics and Probability 24 works
  8. 8 Urticaria and Related Conditions Rheumatology 22 works
  9. 9 Complement system in diseases Immunology 22 works
  10. 10 CAR-T cell therapy research Oncology 21 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.8%not open69.2%

World: 40% of research is openly available.

with international co-authors40.1%domestic only59.9%

World: 18% is written across borders.

How has Novartis (Switzerland)'s research output changed?

Output in 2022-2025 was 19% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Novartis (Switzerland) as a percentage of every work published that year, 0.0081% in 2024.

still counting0.020%0.040%0.060%Novartis (Switzerland)0.0072% in 202519801990200020102020

Fractional works of Novartis (Switzerland) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%30%Novartis (Switzerland)13.8% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 20.3% in 2009.

Other research institutions in Basel

All research institutions in Basel

Compare Novartis (Switzerland) with

Compare any two

Share Novartis (Switzerland)'s ranking

Novartis (Switzerland) on Science Explorer

A card with Novartis (Switzerland)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website2Each links back here and updates with every snapshot

Its overall standing, then the domains, fields and subfields where Novartis (Switzerland) is in the world's top ten or its top 1%. Each has an image of its own.

Overall

Domains

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Questions people ask

What does Novartis publish research on?

In research, Novartis (Switzerland) stands highest in Health Sciences (#369 of 9,902 worldwide), Medicine (#352 of 8,541 worldwide) and Life Sciences (#332 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Hematology, Genetics and Statistics and Probability (Hematology is 15.1× its share of world research).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Novartis (Switzerland). Posts are plain text and can be reported.